SynthesisFrontiers in medicine2023

The efficacy and safety of tyrosine kinase 2 inhibitor deucravacitinib in the treatment of plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials.

Jingyue Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.